Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab
11 janv. 2023 07h10 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health Dealmakers’ Intentions Survey Sees “Optimism” for M&A and Licensing Deals in 2023
10 janv. 2023 07h00 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 13th annual Dealmakers’...
Syneos Health Announces Chief Financial Officer Transition
09 janv. 2023 16h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that, effective March 31,...
Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 janv. 2023 16h31 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
Syneos Health Extends Partnership with Medable
13 déc. 2022 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has extended its strategic...
Syneos Health Releases 2023 Health Trends
01 déc. 2022 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2023 Health Trends:...
Syneos Health to Participate in Fireside Chat at the 2022 Evercore ISI HealthCONx Conference
17 nov. 2022 16h44 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
Syneos Health Reports Third Quarter 2022 Results
04 nov. 2022 06h10 HE
|
Syneos Health, Inc.
Revenue for the third quarter of $1,336.2 million decreased 0.9% on a reported basis and increased 2.2% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health Adds HUB Patient Suite to Deployment Solutions Business
27 oct. 2022 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it is introducing a dedicated...
Syneos Health Schedules Third Quarter 2022 Earnings Call for Friday, November 4, 2022
21 oct. 2022 16h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 21, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2022 financial...